聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 35 分钟 57 秒 前

Auxilium and Sobi Announce Encore Presentation of XIAFLEX/Xiapex Data at European Association of Urology Congress

周一, 04/14/2014 - 12:19
Encore Data Highlighted from Trials Evaluating XIAFLEX, the First and Only FDA Approved Treatment for Peyronie's Disease CHESTERBROOK, Pa. and STOCKHOLM, April 14, 2014 -- (Healthcare Sales & Marketing Network) -- Auxilium Pharmaceuticals, Inc. (AUXL) ...
Biopharmaceuticals, Urology
Auxilium Pharmaceuticals, Swedish Orphan Biovitrum, XIAFLEX, Xiapex, Peyronie's

Toshiba Is First CT Manufacturer to Meet Security Guidelines of the U.S. Department of Defense for Connection to Air Force Network

周一, 04/14/2014 - 12:11
TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--Toshiba America Medical Systems, Inc. received approval to operate (ATO) with the U.S. Air Force, making Toshiba the only current manufacturer to have a fully certified CT system for use on the Air Fo...
Devices, Radiology
Toshiba America Medical Systems, ATO status

Covidien Implements Voluntary Recall of its Pipeline(TM) Embolization Device and Alligator(TM) Retrieval Device

周五, 04/11/2014 - 15:04
DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc today announced that it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline™ Embolization Device and Alligator™ Retrieval Device where the ...
Devices, Product Recall
Covidien, Pipeline Embolization Device, Alligator Retrieval Device

Gilead’s Sovaldi(R) Demonstrates Efficacy and Safety Among Chronic Hepatitis C Patients with Advanced Liver Disease

周五, 04/11/2014 - 15:03
Benefit in Patients with Decompensated Cirrhosis and Recurrent HCV Infection Following Liver Transplantation LONDON--(Healthcare Sales & Marketing Network)--Gilead Sciences, Inc. (GILD) today announced data from two Phase 2 studies and a compassionate a...
Biopharmaceuticals
Gilead Sciences, Sovaldi, sofosbuvir, hepatitis C virus

Kite Pharma Expands Company's Board of Directors with the Appointment of Jonathan M. Peacock

周五, 04/11/2014 - 15:00
SANTA MONICA, Calif., April 11, 2014 -- (Healthcare Sales & Marketing Network) -- Kite Pharma, Inc. (Kite), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer,...
Biopharmaceuticals, Personnel
Kite Pharma, eACT

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong